Arce BB, Martínez FJI, Montoya MM, Sandoval RAG, Urías RVEG, Medina LFJ, Chacón UEJ

Language: Spanish
References: 10
Page: 6-10
PDF size: 200.86 Kb.

ABSTRACT

Background: The increased prevalence of diabetic patients who undergo surgical procedures, as well as the complications related to them, make an appraisal and appropriate preoperative management extremely important. Material and methods: An observational, descriptive, prospective, cross-sectional study was performed in diabetic patients scheduled for elective surgery attending pre-anesthetic assessment, in order to know the prevalence of uncontrolled blood glucose, valued by HbA1c. The study was conducted during the period from September 2013 to September 2014. 4,476 patients showed up. 522 patients had diabetes mellitus 2, of which 451 had a fasting glucose ‹ 180 mg/dL, so they were considered candidates to undergo elective surgery. The final sample for this study was 410 patients. Basal glucose was measured prior to the pre-anesthetic assessment, where patient data were documented; subsequently, measurement of HbA1c was conducted before entering the operating room. Glycemic lack of control: glycosylated hemoglobin › 7%. Results: Of the 410 patients, only 182 (44.4%) were controlled (HbA1c ‹ 7) and 55.6% had uncontrolled blood glucose HbA1c › 7%. Age was the only variable related to glycemic impairment (p = .048). Conclusions: There is a high prevalence (55.6% patients with HbA1c › 7%) of glycemic impairment in patients undergoing surgical procedures at this institution. The only significant variable related to glycemic impairment was age. Presumably, the marked difference between the values of fasting glucose and HbA1c may be due to a lack of health culture in patients attending our institution. Conducting more studies on this issue with a greater methodological validity is needed.

REFERENCES

1. National Diabetes Statistics Report. ADA, CDC. [Actualizado 1 de febrero de 2016; citado 10 de jun de 2014]. Disponible en: http://www.diabetes.org/diabetes-basics/statistics/?loc=db-slabnav

2. Encuesta Nacional de Salud y Nutrición 2012. ENSANUT [Citado 2012]. Disponible en: http://ensanut.insp.mx/doctos/ENSANUT2012_Sint_Ejec-24oct.pdf

3. Cefalu WT, Bakris G, Blonde L, Bolton AJM, De Groot M, Green EL et al. American Diabetes Association. Standards of medical care in diabetes 2015. Diabetes Care. 2015; 38 (Suppl. 1): S1-S93.

4. Davidson MB, Schriger DL, Peters AL, Lorber B. Relationship between fasting plasma glucose and glycosylated hemoglobin: potential for false-positive diagnoses of type 2 diabetes using new diagnostic criteria. JAMA. 1999; 281 (13): 1203-1210.

5. Engoren M, Schwann TA, Arslanian-Engoren C, Maile M, Habib RH. U-shape association between hemoglobin A1c and late mortality in patients with heart failure after cardiac surgery. Am J Cardiol. 2013; 111 (8): 1209-1213.

6. Smiley DD, Umpierrez GE. Perioperative glucose control in the diabetic or nondiabetic patient. South Med J. 2006; 99 (6): 580-589; quiz 590-591.

7. Knapik P, Cies'la D, Filipiak K, Knapik M, Zembala M. Prevalence and clinical significance of elevated preoperative glycosylated hemoglobin in diabetic patients scheduled for coronary artery surgery. Eur J Cardiothorac Surg. 2011; 39 (4): 484-489.

8. Tsuruta R, Miyauchi K, Yamamoto T, Dohi S, Tambara K, Dohi T et al. Effect of preoperative hemoglobin A1c levels on long-term outcomes for diabetic patients after off-pump coronary artery bypass grafting. J Cardiol. 2011; 57 (2): 181-186.

9. Selvin E, Steffes MW, Zhu H, Matsushita K, Wagenknecht L, Pankow J et al. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med. 2010; 362 (9): 800-811.

10. Ramos-Domínguez AL, Rojas-Zárate G, Solís-Páez F. Evaluación de hemoglobina glicosilada en pacientes diabéticos del Centro de Salud de Teocelo Veracruz. Rev Med UV. 2008; 8 (2): 11-13.